These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 6894209)
21. Selective binding of sucralfate to ulcer lesion. III. Experiments in rats with duodenal ulcer receiving 14C-sucralfate. Nagashima R; Hinohara Y; Hirano T Arzneimittelforschung; 1980; 30(1):88-91. PubMed ID: 6892778 [TBL] [Abstract][Full Text] [Related]
22. Comparison of the healing capacities of sucralfate and cimetidine in the short-term treatment of duodenal ulcer: a double-blind randomized trial. Martin F; Farley A; Gagnon M; Bensemana D Gastroenterology; 1982 Mar; 82(3):401-5. PubMed ID: 6895626 [TBL] [Abstract][Full Text] [Related]
23. Relapse rates following initial ulcer healing with sucralfate and cimetidine. Marks IN; Wright JP; Lucke W; Girdwood AH Scand J Gastroenterol Suppl; 1983; 83():53-6. PubMed ID: 6579632 [TBL] [Abstract][Full Text] [Related]
24. Ulcer healing and relapse rates after initial treatment with cimetidine or sucralfate. Marks IN; Lucke W; Wright JP; Girdwood AH J Clin Gastroenterol; 1981; 3(Suppl 2):163-5. PubMed ID: 7033353 [TBL] [Abstract][Full Text] [Related]
25. [Ulcer-healing and mucosa-stimulating properties of Sucralfate. A comparative study of cimetidine]. Guslandi M; Ballarin E; Tittobello A Fortschr Med; 1982 Oct; 100(38):1778-80. PubMed ID: 6897232 [No Abstract] [Full Text] [Related]
26. Sucralfate, bismuth compounds, substituted benzimidazoles, trimipramine and pirenzepine in the short- and long-term treatment of duodenal ulcer. Tytgat GN; Hameeteman W; van Olffen GH Clin Gastroenterol; 1984 May; 13(2):543-68. PubMed ID: 6378446 [No Abstract] [Full Text] [Related]
28. Prevention of experimental duodenal ulcer in the rat by sucralfate. Smolow CR; Bank S; Ackert G; Anfang C; Kranz V Scand J Gastroenterol Suppl; 1983; 83():15-6. PubMed ID: 6138854 [TBL] [Abstract][Full Text] [Related]
32. [New ulcer drugs: is cimetidine out of date?]. Fimmel CJ; Sabbatini F; Pace F; Caradonna P; Blum AL Ther Umsch; 1982 Nov; 39(11):841-51. PubMed ID: 6294895 [No Abstract] [Full Text] [Related]
33. Summary of the 30th meeting of the Food and Drug Administration Gastrointestinal Drugs Advisory Committee January 16-17, 1986. Lewis JH Am J Gastroenterol; 1986 Jun; 81(6):495-8. PubMed ID: 3518411 [No Abstract] [Full Text] [Related]
34. Effect of food and antacid on binding of sucralfate to normal and ulcerated gastric and duodenal mucosa in rats. Giesing DH; Bighley LD; Iles RL J Clin Gastroenterol; 1981; 3(Suppl 2):111-6. PubMed ID: 6895642 [TBL] [Abstract][Full Text] [Related]
36. More about refractory duodenal ulcers. Guslandi M Gut; 1984 Dec; 25(12):1433-4. PubMed ID: 6150884 [No Abstract] [Full Text] [Related]
37. The association of ranitidine and sucralfate in the short-term treatment of duodenal ulcers, as compared to other forms of treatment. Magnanelli M; Belvisi A; Toninelli A; Matergi M; Camarri E Int J Tissue React; 1984; 6(2):189-93. PubMed ID: 6329980 [TBL] [Abstract][Full Text] [Related]
38. A comparison of cimetidine and sucralfate in the treatment of bleeding peptic ulcers. Goldfarb JP; Czaja MJ Am J Gastroenterol; 1985 Jan; 80(1):5-7. PubMed ID: 3881014 [TBL] [Abstract][Full Text] [Related]
39. [Special form of cytoprotection: a local protective layer on the peptic ulcer]. Miederer SE; Haberland D Wien Med Wochenschr; 1983; 133(4-5):98-103. PubMed ID: 6344446 [No Abstract] [Full Text] [Related]